Conventional methods, such as liposome transfection, are largely ineffective in primary neurons, with efficiencies below 3%. At ANRim, our scientists have optimized intracellular delivery and cell engineering technologies specifically for neuronal cells.

• Transfection rate: 45%
• Cell viability: >85%
• Applicable to neurons at different developmental stages
• Engineered cells show normal cell development and functional synapse formation